Find clinical trials for Colon Cancer in Budapest, Budapest

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colorectal Cancer

Colonic Cancer

Cancer

Neoplasm Metastasis

Adenocarcinoma

Lung Cancer

Pancreatic Cancer

Colon Cancer trials near Budapest, Budapest, HUN:

A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer (FRESCO-2)

plus BSC in participants with refractory metastatic colorectal cancer (mCRC). 691 participants were randomized to one of the following treat...

Active, not recruiting

Metastatic Colorectal Cancer

Metastatic Colon Cancer

Drug: Fruquintinib

Drug: Placebo

Phase 3

HUTCHMED

Budapest, HUN, Hungary and 152 other locations

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (SPARTA)

To assess:efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification,...

Enrolling

Colon Cancer

Lung Cancer

Drug: APL-101 Oral Capsules

Phase 2

Apollomics

Budapest, Hungary and 90 other locations

Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy. (SOLSTICE)

The main purpose of this study is to demonstrate the superiority of S 95005 in combination with bevacizumab over capecitabine in combination with bev...

Active, not recruiting

Metastatic Colorectal Cancer

Biological: Bevacizumab experimental

Drug: Trifluridine/tipiracil hydrochloride (S95005)

Phase 3

Servier

Budapest, Hungary and 189 other locations

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)

Phase 1 dose escalation will determine the first cycle dose-limiting toxicities (DLTs), the maximum tolerated dose (MTD), the biologically effective...

Enrolling

Locally Advanced Solid Tumors

Metastatic Solid Tumors

Drug: Oral repotrectinib (TPX-0005)

Phase 1, Phase 2

Turning Point Therapeutics

Budapest, Hungary and 148 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms